<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04354506</url>
  </required_header>
  <id_info>
    <org_study_id>AFapp</org_study_id>
    <nct_id>NCT04354506</nct_id>
  </id_info>
  <brief_title>Smart Phone Atrial Fibrillation Application</brief_title>
  <official_title>Assessing Management of Patients With Atrial Fibrillation Through a Smart Phone Application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Longevity</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Longevity</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with atrial fibrillation will have the chance to assess their disease management
      through an application available for free in Android and IOS smart devices
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Atrial fibrillation recurrence</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical episodes of atrial fibrillation, hospitalisation for atrial fibrillation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke incidence</measure>
    <time_frame>1 year</time_frame>
    <description>Ischemic or hemorrhagic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding incidence</measure>
    <time_frame>1 year</time_frame>
    <description>GI bleeding, urinary bleeding necessitating hospitalisation</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible patients downloading specific AF mobile technology application
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Paroxysmal or persistent atrial fibrillation

        Exclusion Criteria:

        unable to provide informed consent unable to have 1 year of follow‚Äêup for any reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dimitris Tsiachris, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Longevity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dimitris Tsiachris, MD, PHD</last_name>
    <phone>+306944849926</phone>
    <email>dtsiachris@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Athanasios Kordalis, MD, PHD</last_name>
    <phone>6972225950</phone>
    <email>akordalis@gmail.com</email>
  </overall_contact_backup>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute of Longevity</investigator_affiliation>
    <investigator_full_name>Dimitris Tsiachris</investigator_full_name>
    <investigator_title>Electrophysiology and Pacing Lab Director, Athens Heart Center</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>mobile technology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

